ESI Element Solutions Inc
Miscellaneous Chemical Products · NYSE · SEC CIK 1590714 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY39.6%
TTM net income YoY-14.4%
TTM EPS YoY-14.1%
Revenue 3-yr CAGR14.4%
Net income 3-yr CAGR56.3%
Margins
Gross margin36.6%
Operating margin11.7%
Net margin5.9%
FCF margin5.2%
EBITDA margin14.9%
Returns
ROE7.4%
ROA3.8%
ROIC (approx.)6.3%
Asset turnover0.64x
Leverage & solvency
Liabilities / assets50.7%
Debt / equity0.72x
Current ratio2.78x
Interest coverage—
Cash quality & payout
Operating cash flow / net income1.38x
Accruals ratio-1.4%
Payout ratio38.4%
Capex / revenue2.9%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $995.30M | $977.90M | $840.00M | $676.20M | $656.10M | $625.20M | $593.70M | $624.20M |
| Cost of revenue | $652.90M | $643.90M | $517.30M | $399.60M | $379.10M | $358.80M | $343.20M | $368.20M |
| Gross profit | $342.40M | $334.00M | $322.70M | $276.60M | $277.00M | $266.40M | $250.50M | $256.00M |
| R&D expense | $22.90M | $19.50M | $20.20M | $17.40M | $18.10M | $16.20M | $15.90M | $14.40M |
| SG&A expense | $205.60M | $200.80M | $191.10M | $189.50M | $158.10M | $155.90M | $157.20M | $166.70M |
| Operating income | $113.90M | $113.70M | $111.40M | $69.70M | $100.80M | $94.30M | $77.40M | $74.90M |
| Pretax income | $93.30M | $107.10M | $82.70M | $31.00M | $55.50M | $63.30M | $115.80M | $66.80M |
| Income tax | $27.60M | $29.80M | $26.70M | $24.80M | $16.20M | $15.80M | $17.80M | $12.00M |
| Net income | $65.70M | $77.30M | $55.90M | $6.10M | $39.30M | $47.40M | $98.00M | $54.70M |
| EBITDA | $128.70M | $128.90M | $153.90M | $106.90M | $110.80M | $104.00M | $114.60M | $112.70M |
| EPS (basic) | 0.27 | 0.32 | 0.23 | — | 0.16 | 0.20 | 0.40 | — |
| EPS (diluted) | 0.27 | 0.32 | 0.23 | — | 0.16 | 0.20 | 0.40 | — |
| Dividends declared per share | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 |
| Weighted avg. shares (diluted) | 243.70M | 243.90M | 243.70M | — | 242.00M | 242.20M | 243.00M | — |
| Banking | ||||||||
| Net interest income | -$22.80M | -$24.00M | -$21.50M | -$12.90M | -$13.30M | -$12.90M | -$14.30M | -$13.90M |
| Balance sheet | ||||||||
| Cash & equivalents | $224.90M | $189.60M | $177.30M | $626.50M | $594.30M | $529.90M | $499.20M | $359.40M |
| Receivables | $736.10M | $711.00M | $676.90M | $517.70M | $502.20M | $496.70M | $454.70M | $439.60M |
| Inventory | $409.40M | $417.50M | $421.60M | $294.70M | $290.90M | $283.80M | $269.90M | $246.20M |
| Current assets | $1.58B | $1.52B | $1.46B | $1.58B | $1.53B | $1.45B | $1.36B | $1.27B |
| PP&E, net | $425.80M | $408.80M | $403.30M | $319.60M | $300.10M | $296.60M | $283.80M | $276.80M |
| Goodwill | $2.55B | $2.54B | $2.54B | $2.24B | $2.23B | $2.24B | $2.16B | $2.13B |
| Intangibles | $987.30M | $1.00B | $1.03B | $657.20M | $675.60M | $706.20M | $713.70M | $732.00M |
| Total assets | $5.86B | $5.78B | $5.74B | $5.10B | $5.05B | $5.00B | $4.79B | $4.87B |
| Current liabilities | $566.60M | $523.80M | $543.60M | $429.90M | $376.70M | $354.90M | $344.60M | $379.70M |
| Short-term debt | $27.90M | $62.90M | $97.90M | $0 | $0 | $0 | $0 | $10.40M |
| Long-term debt | $2.05B | $2.06B | $2.06B | $1.63B | $1.63B | $1.62B | $1.62B | $1.81B |
| Total debt | $2.08B | $2.12B | $2.16B | $1.63B | $1.63B | $1.62B | $1.62B | $1.82B |
| Total liabilities | $2.97B | $2.96B | $2.99B | $2.41B | $2.38B | $2.36B | $2.26B | $2.48B |
| Shareholders' equity | $2.87B | $2.81B | $2.73B | $2.67B | $2.65B | $2.63B | $2.52B | $2.38B |
| Net debt | $1.86B | $1.93B | $1.98B | $999.40M | $1.03B | $1.09B | $1.12B | $1.46B |
| Cash flow statement | ||||||||
| Operating cash flow | $159.20M | $99.60M | -$66.60M | $91.10M | $100.10M | $72.60M | $26.00M | $138.70M |
| Capital expenditure | $30.40M | $27.90M | $25.10M | $17.00M | $16.50M | $17.70M | $11.00M | $22.30M |
| Free cash flow | $128.80M | $71.70M | -$91.70M | $74.10M | $83.60M | $54.90M | $15.00M | $116.40M |
| Investing cash flow | -$30.30M | -$29.40M | -$889.30M | -$18.80M | -$18.20M | -$14.50M | $337.60M | -$17.40M |
| Financing cash flow | -$95.30M | -$57.40M | $507.80M | -$39.30M | -$15.10M | -$38.70M | -$227.30M | -$124.30M |
| Depreciation & amortization | $14.80M | $15.20M | $42.50M | $37.20M | $10.00M | $9.70M | $37.20M | $37.80M |
| Stock-based compensation | $18.20M | $12.60M | $8.10M | $37.10M | $4.50M | $6.30M | $5.00M | $3.30M |
| Dividends paid | $19.50M | $19.60M | $20.20M | $19.40M | $19.30M | $19.30M | $19.80M | $19.40M |
| Share buybacks | $37.70M | — | — | $5.60M | $0 | — | — | $0 |
Free plan shows the latest 8 periods; Pro shows all 55 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.